Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 5/4/2020
SIETES contiene 92957 citas

 
 
 1 a 20 de 27 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita originalTiene citas relacionadas Cita con resumen
Mitjà O, Godornes C, Houinei W, Kapa A, Paru R, Abel H, González-Beiras C, Bieb SV, Wangi J, Barry AE, Sanz S, Bassat Q, Lukehart SA. Re-emergence of yaws after single mass azithromycin treatment followed by targeted treatment: a longitudinal study. Lancet 2018;391:21 de abril. [Ref.ID 102568]
2.Enlace a cita originalTiene citas relacionadas Cita con resumen
Šmajs D, Pospíšilová P. Macrolide resistance in yaws. Lancet 2018;391:21 de abril. [Ref.ID 102567]
3. Cita con resumen
Anónimo. FDA announces list of off-patent drugs with no competition. DIA Daily 2017:1. [Ref.ID 101658]
4. Cita con resumen
Ralph AP, Noonan S, Boardman C, Halkon C, Currie BJ. Prescribing for people with acute rheumatic fever. Australian Prescriber 2017;40:70-5. [Ref.ID 101520]
5. Cita con resumen
Bowen AC, Tong SY, Andrews RM, O'Meara IM, McDonald MI, Chatfield MD, Currie BJ, Carapetis JR. Short-course oral co-trimoxazole versus intramuscular benzathine benzylpenicillin for impetigo in a highly endemic region: an open-label, randomised, controlled, non-inferiority trial. Lancet 2014;384:2132-40. [Ref.ID 98455]
6.Tiene citas relacionadas Cita con resumen
Mitjà O, Hays R, Ipai A, Penias M, Paru R, Fagaho D, de Lazzari E, Bassat Q. Single-dose azithromycin versus benzathine benzylpenicillin for treatment of yaws in children in Papua New Guinea: an open-label, non-inferiority, randomised trial. Lancet 2012;379:342-7. [Ref.ID 92288]
7.Tiene citas relacionadas Cita con resumen
Mabey D. Oral azithromycin for treatment of yaws. Lancet 2012;379:295-7. [Ref.ID 92284]
8. Cita con resumen
Hook EW, Behets F, Van Damme K, Ravelomanana N, Leone P, Sena AC, Martin D, Langley C, McNeil L, Wolff M. A phase III equivalence trial of azithromycin versus benzathine penicillin for treatment of early syphilis. J Infect Dis 2010;201:1729-35. [Ref.ID 88959]
9. Cita con resumen
Campbell OMR, Graham WJ, on behalf of The Lancet Maternal Survival Series steering group. Strategies for reducing maternal mortality: getting on with what works. Lancet 2006;368:1284-99. [Ref.ID 78143]
10.Tiene citas relacionadas
Holmes KK. Azithromycin versus penicillin G benzathine for early syphilis. N Engl J Med 2005;353:1291-3. [Ref.ID 74841]
11.Tiene citas relacionadas Cita con resumen
Riedner G, Rusizoka M, Todd J, Maboko L, Hoelscher M, Mmbando D, Samky E, Lyamuya E, Mabey D, Grosskurth H, Hayes R. Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis. N Engl J Med 2005;353:1236-44. [Ref.ID 74838]
12. Cita con resumen
Carapetis JR, McDonald M, Wilson NJ. Acute rheumatic fever. Lancet 2005;366:155-68. [Ref.ID 74392]
13.
Anónimo. WHO model prescribing information. Streptococcal pharyngitis and prevention of rheumatic fever. WHO Drug Information 2000;14:99-104. [Ref.ID 53486]
14.Tiene citas relacionadas Cita con resumen
Demiroglu H. Behçet's disease and interferon: flaws in research integrity of randomised trial. Lancet 2000;356:1351-2. [Ref.ID 53407]
16.Tiene citas relacionadas Cita con resumen
Dündar S, Özcebe O I. Behçet's disease and interferon: flaws in research integrity of randomised trial. Lancet 2000;356:1351. [Ref.ID 53405]
18.Tiene citas relacionadas Cita con resumen
Horton R. Retraction: Interferon alfa-2b... in Behçet's disease. Lancet 2000;356:1292. [Ref.ID 53395]
19.
Donders GGG. Treatment of sexually transmitted bacterial diseases in pregnant women. Drugs 2000;59:477-85. [Ref.ID 49908]
20. Cita con resumen
Demiroglu H, Özcebe O I, Barista I, Dündar S, Eldem B. Interferon alfa-2b, colchicine, and benzathine penicillin versus colchicine and benzathine penicillin in Behçet's disease: a randomised trial. Lancet 2000;355:605-9. [Ref.ID 49445]
Seleccionar todas
 
 1 a 20 de 27 siguiente >>